NCT02407119View on ClinicalTrials.gov

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

470

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2030

Conditions
Helicobacter Pylori InfectionEarly Gastric CancerEndoscopic Resection
Interventions
DRUG

7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin

Omeprazole 20 mg or Rabeprazole 10 mg bid for 7 days, Clarithromycin 500 mg bid for 7 days, Amoxicillin 1,000 mg bid for 7 days.

DRUG

Placebo, Omeprazole or Rabeprazole, Clarithromycin

Omeprazole 20 mg or Rabeprazole 10 mg bid for 7 days, Placebo for clarithromycin 500 mg bid for 7 days, Placebo for amoxicillin 1,000 mg bid for 7 days.

Trial Locations (1)

410-769

National Cancer Center, Korea, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV